Comprehensive M&A data with integrated detailed company information
Cato SMS snaps up Array
Posted on Wednesday, 16 September 2020 12:27
Cato SMS has acquired US-based biostatistical and statistical programming company Array Biostatistics as it looks to expand its offering of specialised clinical research services.
No financial details were disclosed.
Through the acquisition, Cato SMS will add expertise and scale to its full-service biostatistical consulting, analysis and programming operations.
Following the transaction, the target’s chief executive, Sandy Feber, will continue to lead the business and spearhead the buyer’s biometrics offerings.
North Carolina-headquartered Array provides statistical programming services, clinical study designs and regulatory support and data monitoring for phase 1-to-4 clinical trials.
The group covers a variety of therapeutic areas and assists clients with initial study planning, through to successful submission filings leading to drug and biologics approvals.
Its offerings include statistical analysis, safety reporting and programming specifications for study data tabulation models.
The target’s project leadership strategy programme allows companies to develop detailed timelines for project activities and join regular internal and joint team meetings.
Mark Goldberg, executive chairman of Cato SMS, said: “The Array acquisition furthers our goal of providing our clients with a comprehensive portfolio of specialised solutions to best support development in complex therapeutic areas including oncology, rare and orphan indications, and cell and gene therapy, among others.”
The deal will strengthen the buyer’s operations globally, which includes offices across North America, Europe and the Middle East.
Cato SMS conducts clinical trials in more than 25 countries worldwide and has contributed to the successful development of over 50 marketed products.
According to Zephyr, the M&A database published by Bureau van Dijk, there have been 7,682 deals announced globally since the beginning of 2020.
In the most valuable of these, Teladoc Health agreed to pick up US-based Livongo Health for USD 18.50 billion. The transaction represented the fourth-largest transaction on record for this sector.
Other companies targeted so far this year include the likes of E*Trade Financial, Visma and GrubHub.
© Zephus Ltd